SKIN (SkinHealth Systems) EBITDA Margin %: 7.50% (As of Mar. 2026) — 13% Below Median


SKIN SkinHealth Systems Inc SKIN
49 GF Score
Price $0.64
GF Value $1.50
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is SkinHealth Systems EBITDA Margin %?

SkinHealth Systems SKIN -0.66% 49 EBITDA Margin % is 7.50% as of Mar. 2026, which is 13% below its 10-year median of 8.62. GuruFocus rates SKIN with a GF Score™ of 49/100 and a GF Value™ of $1.50 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,953 Consumer Packaged Goods companies, SkinHealth Systems ranks better than 72.25% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. SkinHealth Systems's EBITDA for the three months ended in Mar. 2026 was $4.9 Mil. SkinHealth Systems's Revenue for the three months ended in Mar. 2026 was $64.9 Mil. Therefore, SkinHealth Systems's EBITDA margin for the quarter that ended in Mar. 2026 was 7.50%.


SkinHealth Systems  (NAS:SKIN) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


SkinHealth Systems EBITDA Margin % Related Terms


SkinHealth Systems EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for SkinHealth Systems's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SkinHealth Systems EBITDA Margin % Chart

SkinHealth Systems Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial -134.93 22.30 -13.46 4.35 12.88

SkinHealth Systems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.78 36.15 5.80 8.40 7.50

SKIN vs SLSN, GROV, WALD: EBITDA Margin % Comparison

For the Household & Personal Products subindustry, SkinHealth Systems's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SkinHealth Systems EBITDA Margin % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, SkinHealth Systems's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where SkinHealth Systems's EBITDA Margin % falls into.


SKIN
49GF Score
SkinHealth Systems Inc SKIN
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SkinHealth Systems EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

SkinHealth Systems's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=38.737/300.79
=12.88 %

SkinHealth Systems's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=4.868/64.91
=7.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 7.50% mean?
SkinHealth Systems (SKIN) has a EBITDA Margin % of 7.50% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on SkinHealth Systems and its competitors. This is 13% below median its historical median of 8.62. According to the industry distribution chart, SkinHealth Systems ranks #542 out of 1953 companies in the Consumer Packaged Goods industry, placing it in the top 27.8%.
Is SkinHealth Systems' EBITDA Margin % too high?
SkinHealth Systems' current EBITDA Margin % of 7.50% is 13% below median its 10-year median of 8.62. The Consumer Packaged Goods industry median EBITDA Margin % is 8.99. SkinHealth Systems' value of 7.50% is 16.6% below this industry median. Based on the distribution chart, SkinHealth Systems ranks #542 out of 1953 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, SkinHealth Systems has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SkinHealth Systems' EBITDA Margin % compare to SLSN and GROV?
According to the Consumer Packaged Goods industry distribution chart, SkinHealth Systems ranks #542 out of 1953 companies for EBITDA Margin %. This puts SkinHealth Systems in the upper half of its industry. The industry median EBITDA Margin % is 8.99. SkinHealth Systems' value of 7.50% is 16.6% below this benchmark. While the company's 10-year median is 8.62 vs. the industry median of 8.99, SkinHealth Systems has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 8.99, based on 1,953 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SkinHealth Systems's current EBITDA Margin % of 7.50% is 16.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on SkinHealth Systems and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 8.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SkinHealth Systems's current EBITDA Margin % is 7.50%, which is 13% below median its own 10-year median of 8.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SkinHealth Systems stock overvalued right now?
Based on GuruFocus' analysis, SkinHealth Systems (SKIN) is currently considered Possible Value Trap. The stock's GF Value™ is $1.50, compared to a current price of $0.64 — trading 57.6% below its estimated fair value. The current EBITDA Margin % is 7.50%, which is 13% below median its 10-year median of 8.62 and 16.6% below the Consumer Packaged Goods industry median of 8.99. SkinHealth Systems' overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For SkinHealth Systems (SKIN), the current EBITDA Margin % is 7.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SkinHealth Systems (SKIN) Overvalued in 2026?

Based on GuruFocus' analysis, SkinHealth Systems stock appears to be undervalued. The current stock price of $0.64 is trading 57.6% below its estimated GF Value™ of $1.50. GuruFocus considers SkinHealth Systems to be Possible Value Trap.

Key valuation signals for SKIN:

  • EBITDA Margin %: 7.50% (13% below median its 10-year median of 8.62)
  • GF Value™: $1.50 vs. price of $0.64 (57.6% below fair value)
  • GF Score™: 49/100 with 4 warning signs
  • Industry Position: 16.6% below the Consumer Packaged Goods median (#542 of 1953)

No single metric tells the full story. See the SKIN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SkinHealth Systems Business Description

Other Exchanges V7A0:Germany
Address 2165 Spring Street, Long Beach, CA, USA, 90806
SkinHealth Systems Inc is a world-wide medical aesthetics company delivering an integrated ecosystem of clinically validated solutions designed to help consumers achieve superior skin health and support the success of providers. Its brands are Hydrafacial and SkinStylus.
49GF Score

Get the complete analysis for SKIN

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.64
Price
$1.50
GF Value